Hyperostosis frontalis interna, acromegaly and hyperprolactinaemia

J D Fulton1, J Shand, D Ritchie

  • 1Department of Geriatric Medicine, Stobhill General Hospital, Glasgow, UK.

Insights

Hyperostosis frontalis interna (HFI) is more common in acromegaly patients, especially those with hyperprolactinaemia. This association warrants further investigation in acromegaly management.

Area of Science:

  • Endocrinology
  • Radiology
  • Medical Imaging

Background:

  • Hyperostosis frontalis interna (HFI) is a condition characterized by thickening of the inner table of the frontal bone.
  • Acromegaly is a hormonal disorder caused by excessive growth hormone production.
  • Hyperprolactinaemia is a condition of elevated prolactin levels in the blood.

Purpose of the Study:

  • To investigate the association between hyperostosis frontalis interna (HFI) and acromegaly.
  • To determine if hyperprolactinaemia influences the prevalence of HFI in acromegalic patients.

Main Methods:

  • Skull X-rays of 36 acromegalic patients (19 with hyperprolactinaemia) were compared to 36 age-sex matched controls.
  • Intra- and interobserver variability for HFI assessment was evaluated.
  • Subgroup analyses were performed comparing acromegalics and acromegalics with hyperprolactinaemia to controls.

Main Results:

  • HFI was significantly more prevalent in the acromegalic cohort compared to controls (P = 0.0002).
  • This association was observed in both male and female acromegalic patients.
  • Acromegalic patients with hyperprolactinaemia showed a higher HFI prevalence than controls (P = 0.0001).
  • HFI severity correlated with age in both sexes and with disease duration in females.

Conclusions:

  • A strong association exists between HFI and acromegaly, particularly when hyperprolactinaemia is present.
  • The findings suggest HFI may have symptomatic significance in acromegaly.
  • Confirmation or refutation of HFI is recommended for all acromegaly patients.

Related Concept Videos

Cranial Bones: Superior and Posterior View01:14

Cranial Bones: Superior and Posterior View

The superior view of the cranium shows the frontal and paired parietal bones.
The frontal bone is the single bone that forms the forehead. At its anterior midline, between the eyebrows, there is a slight depression called the glabella. The frontal bone also forms the supraorbital margin of the orbit. Near the middle of this margin is the supraorbital foramen, the opening that provides passage for a sensory nerve to the forehead. The frontal bone is thickened just above each supraorbital margin,...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...